Immuneering Corporation
IMRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,965 | -$14,434 | -$15,046 | -$18,051 |
| Dep. & Amort. | $86 | $92 | $93 | $175 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,525 | $1,692 | $0 |
| Change in WC | $1,358 | $3,286 | -$903 | $1,692 |
| Other Non-Cash | $1,543 | $85 | $83 | $1,675 |
| Operating Cash Flow | -$11,977 | -$9,446 | -$14,081 | -$14,511 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$2 | -$9 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $5,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7 | -$2 | -$9 | $5,491 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $213,192 | -$62 | $13,677 | -$416 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $134 | $375 |
| Financing Cash Flow | $213,192 | -$62 | $13,811 | -$41 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $201,208 | -$9,510 | -$279 | -$9,061 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,355 | $35,866 | $36,145 | $45,206 |
| End Cash | $227,563 | $26,355 | $35,866 | $36,145 |
| Free Cash Flow | -$11,984 | -$9,448 | -$14,090 | -$14,520 |